Loomis, Sayles & Company’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Loomis, Sayles & Company's ALHC Position: Q2 2026 in Review
Loomis, Sayles & Company increased its Alignment Healthcare (ALHC) stake by 2% in Q2 2026, buying an estimated $821K and bringing the position to 2,148,864 shares worth $51.2M. The position accounts for 0.06% of the portfolio, ranked #111.
Loomis, Sayles & Company first reported a position in ALHC in Q3 2022 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Loomis, Sayles & Company held 2,148,864 shares of Alignment Healthcare worth $51.2M as of Q2 2026.
- Loomis, Sayles & Company bought 42,796 Alignment Healthcare shares in Q2 2026, an estimated $821K.
- Alignment Healthcare made up 0.06% of Loomis, Sayles & Company's portfolio in Q2 2026, its #111 holding.
- Loomis, Sayles & Company first reported a position in Alignment Healthcare in Q3 2022 and has held it in 6 quarters since.
- 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.